Tag: urothelial
Merck: Keytruda partially convinces in urothelial cancer
(CercleFinance.com) – Merck today presents results from a phase III trial evaluating Keytruda as adjuvant treatment for patients with localized muscle invasive urothelial carcinoma (MIUC) and locally advanced resectable urothelial…
Merck and co inc: Keytruda partially convinces in urothelial cancer
Read also (CercleFinance.com) – Merck today presents results from a phase III trial evaluating Keytruda as adjuvant treatment for patients with localized muscle invasive urothelial carcinoma (MIUC) and locally advanced…
Merck and co inc: Positive data in urothelial cancer
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…